The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
On February 11, 2025, the Food and Drug Administration approved mirdametinib, a kinase inhibitor, for…
The Tisch Cancer Institute at Mount Sinai, USA, has uncovered a major reason why some…
Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their…
Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related…
A new study from the UK found that a mobile prostate cancer screening clinic called…
Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a…
When a tumour develops, it creates a structure around itself called the tumour stroma, within…
A new report highlights the overwhelming economic and societal cost of ovarian cancer in Australia.…
A collaborative research team led by Professor Jinah Jang from the Department of Mechanical Engineering…
A type of aggressive, treatment-resistant brain tumour has a distinct population of immune cells that…